The emerging role of CTLA-4 as an immune attenuator

Immunity

Volumn 7, Issue 4, 1997, Pages 445-450

  Thompson, Craig B ^a   Allison, James P ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; HUMAN; IMMUNOMODULATION; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030694234     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80366-0     Document Type: Review

References (40)

1. Abbas, A.K. (1996). Die and let live: eliminating dangerous lymphocytes. Cell 84, 655-657.
2. Alegre, M-L., Noel, P.J., Eisfelder, B.J., Chuang, E., Clark, M.R., Reiner, S.L., and Thompson, C.B. (1996). Regulation of surface and intracellular expression of CTLA-4 on mouse T cells. J. Immunol. 157, 4762-4770.
3. Borriello, F., Sethna, M.P., Boyd, S.D., Schweitzer, A.N., Tivol, E.A., Jacoby, D., Strom, T.B., Simpson, E.M., Freeman, G.J., and Sharpe, A.M. (1997). B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303-313.
4. Chambers, C.A., Krummel, M.F., Boittel, B., Hurwitz, A.A., Sullivan, T.J., Fournier, S., Cassell, D., Brunner, M., and Allison, J.P. (1996). The role of CTLA-4 in the regulation and initiation of T cell responses. Immunol. Rev. 153, 27-46.
5. Chambers, C.A., Cado, D., Truong, T., and Allison, J.P. (1997). Thymocyte differentiation occurs normally in the absence of CTLA-4. Proc. Natl. Acad. Sci. USA, in press.
6. Chuang, E., Alegre, M-L., Duckett, C.S., Noel, P.J., Vander Heiden, M.G., and Thompson, C.B. (1997). Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159, 144-151.
7. Donner, H., Rau, H., Walfish, P.G., Braun, J., Siegmund, T., Finke, R., Herwig, J., Usadel, K.H., and Badenhoop, K. (1997). CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82, 143-146.
8. Green, J.M., Noel, P.J., Sperling, A.I., Walunas, T.L., Gray, G.S., Bluestone, J.A., and Thompson, C.B. (1994). Absence of B7-dependent responses in CD28-deficient mice. Immunity 1, 501-508.
9. Gribben, J.G., Freeman, G.J., Boussiotis, V.A., Rennert, P., Jellis, C.L., Greenfield, E., Barber, M., Restivo, V.A., Ke, X., Gray, G.S., et al. (1995). CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92, 811-815.
10. Hurwitz, A.A., Sullivan, T.J., Krummel, M.F., Sobel, R.A., and Allison, J.P. (1997). Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J. Neuroimmunol. 73, 57-62.
11. Hutchcroft, J.E., and Bierer, B.E. (1996). Signaling through CD28/ CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase. J. Immunol. 156, 4071-4074.
12. Karandikar, N.J., Vanderlugt, C.L., Walunas, T.L., Miller, S.D., and Bluestone, J.A. (1996). CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184, 783-788.
13. Kearney, E.R., Walunas, T.L., Karr, R.W., Morton, P.A., Loh, D.Y., Bluestone, J.A., and Jenkins, M.K. (1995). Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155, 1033-1036.
14. Krummel, M.F., and Allison, J.P. (1995). CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
15. Krummel, M.F., and Allison, J.P. (1996). CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
16. Krummel, M.F., Sullivan, T.J., and Allison, J.P. (1996). Superantigen responses and costimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immun. 8, 519-523.
17. Kwon, E.D., Hurwitz, A.A., Foster, B.A., Madias, C., Feldhaus, A.L., Greenberg, N.M., Burg, M.B., and Allison, J.P. (1997). Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA 94, 8099-8103.
18. Leach, D., Krummel, M., and Allison, J.P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736.
19. Leung, H.T., Bradshaw, J., Cleveland, J.S., and Linsley, P.S. (1995). Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270, 25107-25114.
20. Lindsten, T., Lee, K.P., Harris, E.S., Petryniak, B., Craighead, N., Reynolds, P.J., Lombard, D.B., Freeman, G.J., Nadler, L.M., Gray, G.S., et al. (1993). Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151, 3489-3499.
21. Linsley, P.S. (1995). Distinct roles for CD28 and Cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182, 289-292.
22. Linsley, P.S., Brady, W., Urnes, M., Grosmaire, L.S., Damle, N.K., and Ledbetter, J.A. (1991). CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174, 561-569.
23. Linsley, P.S., Greene, J.L., Tan, P., Bradshaw, J., Ledbetter, J.A., Anasetti, C., and Damle, N.K. (1992). Coexpression and functional cooperativity of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176, 1595-1604.
24. Linsley, P.S., Bradshaw, J., Greene, J., Peach, R., Bennett, K.L., and Mittler, R.S. (1996). Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4, 535-543.
25. Marengère, L.E.M., Waterhouse, P., Duncan, G.S., Mittrücker, H.-W., Feng, G.-S., and Mak, T.W. (1996). Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170-1173.
26. Nistic, L., Buzzetti, R., Pritchard, L.E., Van der Auwera, B., Giovannini, C., Bosi, E., Larrad, M.T.M., Rios, M.S., Chow, C.C., Cockram, C.S., et al. (1996). The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 5, 1075-1080.
27. Perez, V.L., Van Parijs, L., Biuckians, A., Zheng, X.X., Strom, T.B., and Abbas, A.K. (1997). Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417.
28. Perrin, P.J., Maldonado, J.H., Davis, T.A., June, C.H., and Racke, M.K. (1996). CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157, 1333-1336.
29. Schneider, H., Prasad, K.V.S., Shoelson, S.E., and Rudd, C.E. (1995). CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181, 351-355.
30. Shiratori, T., Miyatake, S., Ohno, H., Nakaseko, C., Isono, K., Bonifacino, J., and Spito, T. (1997). Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin associated adaptor complex AP-2. Immunity 6, 583-589.
31. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
32. Todd, J.A., and Farrall, M. (1996). Panning for gold: genome-wide scanning for linkage in type 1 diabetes. Hum. Mol. Genet. 5, 1443-1448.
33. van der Merwe, P.A., Bodian, D.L., Daenke, S., Linsley, P., and Davis, S.J. (1997). CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185, 393-403.
34. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
35. Walunas, T.L., Bakker, C.Y., and Bluestone, J.A. (1996). CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550.
36. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988.
37. Waterhouse, P., Marengère, L.E.M., Mittrücker, H-W., and Mak, T.W. (1996). CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 153, 183-207.
38. Wu, Y., Guo, Y., Huang, A., Zheng, P., and Liu, Y. (1997). CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 185, 1327-1335.
39. Yanagawa, T., Hidaka, Y., Guimaraes, V., Soliman, M., and DeGroot, L.J. (1995). CTLA-4 gene polymorphism associated with Graves' disease in a caucasian population. J. Clin. Endocrinol. Metab. 80, 41-45.
40. Zhang, Y., and Allison, J.P. (1997). Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc. Natl. Acad. Sci. 94, 9273-9278.